摘要: Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. While current therapeutic options for hepatitis are limited, recent progress in the understanding biology HCV led to identification novel targets antiviral intervention. In addition, molecular immunotherapeutic strategies inhibit replication or gene expression enhance cellular immune response against being explored. These other may eventually complement existing modalities. Here, we briefly review concepts epidemiology, virology, pathogenesis, natural history, diagnosis, therapy, prevention C.
smw.ch 参考文章(52)
Akinobu Takaki, Manfred Wiese, Geert Maertens, Erik Depla, Ulrike Seifert, Anke Liebetrau, Jeffery L. Miller, Michael P. Manns, Barbara Rehermann, Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nature Medicine. ,vol. 6, pp. 578- 582 ,(2000) , 10.1038/75063
Shane Crotty, David Maag, Jamie J. Arnold, Weidong Zhong, Johnson Y. N. Lau, Zhi Hong, Raul Andino, Craig E. Cameron, The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nature Medicine. ,vol. 6, pp. 1375- 1379 ,(2000) , 10.1038/82191
K. E. Reed, C. M. Rice, Overview of Hepatitis C Virus Genome Structure, Polyprotein Processing, and Protein Properties Current Topics in Microbiology and Immunology. ,vol. 242, pp. 55- 84 ,(2000) , 10.1007/978-3-642-59605-6_4
Patricia C. Weber, Charles A. Lesburg, Michael B. Cable, Eric Ferrari, Zhi Hong, Anthony F. Mannarino, Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site Nature Structural & Molecular Biology. ,vol. 6, pp. 937- 943 ,(1999) , 10.1038/13305
F von Weizsäcker, S Wieland, J Köck, W Offensperger, S Offensperger, D Moradpour, H E Blum, Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants. Hepatology. ,vol. 26, pp. 251- 255 ,(1997) , 10.1002/HEP.510260237
Stefano Brillanti, Fabio Levantesi, Livia Masi, Mauro Foli, Luigi Bolondi, Triple Antiviral Therapy as a New Option for Patients With Interferon Nonresponsive Chronic Hepatitis C Hepatology. ,vol. 32, pp. 630- 634 ,(2000) , 10.1053/JHEP.2000.16235
A Cerny, J G McHutchison, C Pasquinelli, M E Brown, M A Brothers, B Grabscheid, P Fowler, M Houghton, F V Chisari, Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. Journal of Clinical Investigation. ,vol. 95, pp. 521- 530 ,(1995) , 10.1172/JCI117694
J H Hoofnagle, Hepatitis C: the clinical spectrum of disease. Hepatology. ,vol. 26, pp. 15- 20 ,(1997) , 10.1002/HEP.510260703
M.E. Lai, A.P. Mazzoleni, A. Balestrieri, F. Argiolu, S. De Virgilis, A. Cao, R.H. Purcell, P. Farci, Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children The Lancet. ,vol. 343, pp. 388- 390 ,(1994) , 10.1016/S0140-6736(94)91224-6
V. Agnello, G. Abel, M. Elfahal, G. B. Knight, Q.-X. Zhang, Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 12766- 12771 ,(1999) , 10.1073/PNAS.96.22.12766